| Literature DB >> 26908917 |
Keisuke Kozai1, Shota Tokuyama1, Anna Z Szóstek2, Yuko Toishi3, Nobuo Tsunoda3, Kazuyoshi Taya3, Miki Sakatani4, Masashi Takahashi5, Yasuo Nambo6, Dariusz J Skarzynski7, Yuki Yamamoto1, Koji Kimura1, Kiyoshi Okuda8.
Abstract
In mares, prostaglandin F2α (PGF2α) secreted from the endometrium is a major luteolysin. Some domestic animals have an auto-amplification system in which PGF2α can stimulate its own production. Here, we investigated whether this is also the case in mares. In an in vivo study, mares at the mid-luteal phase (days 6-8 of estrous cycle) were injected i.m. with cloprostenol (250 µg) and blood samples were collected at fixed intervals until 72 h after treatment. Progesterone (P4) concentrations started decreasing 45 min after the injection and continued to decrease up to 24 h (P < 0.05). In turn, 13,14-dihydro-15-keto-PGF2α (PGFM) metabolite started to increase 4h after an injection and continued to increase up to 72 h (P < 0.05). PGF receptor (PTGFR) mRNA expression in the endometrium was significantly higher in the late luteal phase than in the early and regressed luteal phases (P < 0.05). In vitro, PGF2α significantly stimulated (P < 0.05) PGF2α production by endometrial tissues and endometrial epithelial and stromal cells and significantly increased (P < 0.05) the mRNA expression of prostaglandin-endoperoxide synthase-2 (PTGS2), an enzyme involved in PGF2α synthesis in endometrial cell. These findings strongly suggest the existence of an endometrial PGF2α auto-amplification system in mares.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26908917 DOI: 10.1530/REP-15-0617
Source DB: PubMed Journal: Reproduction ISSN: 1470-1626 Impact factor: 3.906